丝路视觉：2025年前三季度净利润约-1.23亿元

Group 1 - The core viewpoint of the article highlights the financial performance of Silk Road Vision, indicating a decline in revenue and a significant net loss for the third quarter of 2025 [1] - For the first three quarters of 2025, the company's revenue was approximately 393 million yuan, representing a year-on-year decrease of 10.95% [1] - The net profit attributable to shareholders was a loss of approximately 123 million yuan, with basic earnings per share reflecting a loss of 1.01 yuan [1] Group 2 - As of the report, Silk Road Vision has a market capitalization of 2.5 billion yuan [2] - The article also discusses the broader context of the biopharmaceutical market in China, noting that overseas licensing has generated 80 billion US dollars this year [2] - There is a contrast presented between the hot secondary market for biopharmaceuticals and the cooling fundraising environment in the primary market [2]